Associated Papers
Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients.
Chan HT et al.
Frontiers in Oncology, 2022
36776372 (PubMed )
Supplement: DataSheet_1.xlsx › S-10
Select a paper to view details